|
POM121 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.94959997829636E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.9421999804884E-09 |
| Normal-vs-Stage2 |
6.340900E-03 |
| Normal-vs-Stage3 |
4.27440000061452E-08 |
| Normal-vs-Stage4 |
3.97220000000198E-05 |
| Stage1-vs-Stage2 |
1.069970E-01 |
| Stage1-vs-Stage3 |
3.418400E-01 |
| Stage1-vs-Stage4 |
9.122600E-01 |
| Stage2-vs-Stage3 |
5.350100E-02 |
| Stage2-vs-Stage4 |
2.762800E-01 |
| Stage3-vs-Stage4 |
4.728400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.50450000025293E-08 |
| Normal-vs-AfricanAmerican |
1.248120E-02 |
| Normal-vs-Asian |
3.05060000005408E-06 |
| Caucasian-vs-AfricanAmerican |
2.730000E-01 |
| Caucasian-vs-Asian |
7.983600E-01 |
| AfricanAmerican-vs-Asian |
1.955810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.51469999876142E-08 |
| Normal-vs-Female |
6.38899999572118E-08 |
| Male-vs-Female |
2.402600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.24569999870872E-08 |
| Normal-vs-Age(41-60Yrs) |
1.93450000018913E-07 |
| Normal-vs-Age(61-80Yrs) |
2.18009999999325E-05 |
| Normal-vs-Age(81-100Yrs) |
2.231600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.508600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.736800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.286800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.485000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.679400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.067800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.578100E-04 |
| Classical-VS-Follicular |
2.056400E-01 |
| Classical-VS-Other |
8.419700E-02 |
| Classical-VS-Normal |
5.95090000055087E-07 |
| Tall-VS-Follicular |
4.712200E-02 |
| Tall-VS-Other |
7.939600E-01 |
| Tall-VS-Normal |
8.49330050733954E-10 |
| Follicular-VS-Other |
3.267200E-01 |
| Follicular-VS-Normal |
1.5503999999944E-05 |
| Other-VS-Normal |
9.007100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74269999986265E-07 |
| Normal-vs-N1 |
1.37799999999633E-06 |
| N0-vs-N1 |
4.571000E-01 |
|
|
